8-KOther EventsExhibits & Filings

ELI LILLY & Co 8-K Report, Corporate Update (Aug 24, 2004)

Filed August 24, 2004For Securities:LLY

Summary

Eli Lilly and Company (LLY) filed an 8-K on August 24, 2004, primarily noting "Other Events" and "Financial Statements and Exhibits." While the filing itself is brief and lacks specific details within the provided text, it signals that the company has made important disclosures or released financial information on or around August 23, 2004. Investors should refer to the full filing or subsequent releases for the specific nature of these events, which could include significant business updates, regulatory news, or financial performance announcements that may impact the company's valuation. Given the limited information in the 8-K excerpt, it's impossible to provide concrete financial or operational insights. However, the filing serves as a notification that material information was disseminated. Investors are advised to consult the complete 8-K document filed with the SEC on August 24, 2004, to understand the context and implications of the "Other Events" and any accompanying financial statements or exhibits. This filing, though sparse in the provided text, is a crucial part of ongoing corporate transparency.

Key Highlights

  • 1Eli Lilly & Co (LLY) filed an 8-K on August 24, 2004.
  • 2The filing pertains to 'Other Events' (Item 8.01).
  • 3The filing also addresses 'Financial Statements and Exhibits' (Item 9.01).
  • 4The event date reported is August 23, 2004.
  • 5The provided text does not contain specific details about the nature of the events or financial information disclosed.
  • 6Investors need to access the full 8-K filing for comprehensive details.

Frequently Asked Questions

The 8-K filing on August 24, 2004, was primarily to report 'Other Events' (Item 8.01) and to announce the filing of 'Financial Statements and Exhibits' (Item 9.01). This indicates that Eli Lilly had material information or financial updates to disclose to the public on or around August 23, 2004.

The provided excerpt of the 8-K filing does not specify the nature of the 'Other Events.' To understand what these events entailed, investors would need to review the complete 8-K document filed with the SEC on August 24, 2004, which would contain the detailed information.

The filing mentions Item 9.01 concerning 'Financial Statements and Exhibits,' suggesting that financial information was indeed part of the disclosure. However, the text provided does not include any specific financial figures or performance metrics. The full 8-K filing would be necessary to find details on any financial statements or exhibits presented.

For complete details regarding the 'Other Events' and any accompanying 'Financial Statements and Exhibits,' investors should access the full 8-K filing submitted by Eli Lilly and Company (LLY) to the U.S. Securities and Exchange Commission (SEC) on August 24, 2004. This can typically be found on the SEC's EDGAR database or Eli Lilly's investor relations website.